中国船舶工业股份有限公司 换股吸收合并中国船舶重工股份有限公司 暨关联交易报告书摘要 | 证券代码：600150 | 证券简称：中国船舶 | 上市地：上海证券交易所 | | --- | --- | --- | | 证券代码：601989 | 证券简称：中国重工 | 上市地：上海证券交易所 | 中国船舶工业股份有限公司 中国船舶重工股份有限公司 中国（上海）自由贸易试验区浦东大道 1 号 北京市海淀区昆明湖南路 72 号 吸并方 被吸并方 吸并方独立财务顾问 被吸并方独立财务顾问 二〇二五年七月 1 公司声明 一、吸收合并双方及其全体董事、高级管理人员保证重组报告书及其摘要内 容的真实、准确、完整，并对其虚假记载、误导性陈述或重大遗漏负相应的法律 责任。 二、吸收合并双方控股股东及全体董事、高级管理人员承诺，如就本次交易 所提供或披露的信息因涉嫌虚假记载、误导性陈述或者重大遗漏，被司法机关立 案侦查或者被中国证监会立案调查的，在案件调查结论明确之前，将暂停转让各 自在吸收合并双方拥有权益的股份，并于收到立案稽查通知的两个交易日内将暂 停转让的书面申请和股票账户提交吸收合并双方董事会，由董事会代承诺人向证 券交易 ...

| 证券代码：600150 | 证券简称：中国船舶 | 上市地：上海证券交易所 | | --- | --- | --- | | 证券代码：601989 | 证券简称：中国重工 | 上市地：上海证券交易所 | 中国船舶工业股份有限公司 换股吸收合并中国船舶重工股份有限公司 暨关联交易报告书 中国（上海）自由贸易试验区浦东大道 1 号 北京市海淀区昆明湖南路 72 号 吸并方 被吸并方 中国船舶工业股份有限公司 中国船舶重工股份有限公司 吸并方独立财务顾问 被吸并方独立财务顾问 二〇二五年七月 1 中国船舶工业股份有限公司换股吸收合并中国船舶重工股份有限公司暨关联交易报告书 公司声明 一、吸收合并双方及其全体董事、高级管理人员保证本报告书及其摘要内容的真实、 准确、完整，并对其虚假记载、误导性陈述或重大遗漏负相应的法律责任。 二、吸收合并双方控股股东及全体董事、高级管理人员承诺，如就本次交易所提供 或披露的信息因涉嫌虚假记载、误导性陈述或者重大遗漏，被司法机关立案侦查或者被 中国证监会立案调查的，在案件调查结论明确之前，将暂停转让各自在吸收合并双方拥 有权益的股份，并于收到立案稽查通知的两个交易日内将暂停转让的书 ...

中信建投证券股份有限公司 关于 中国船舶工业股份有限公司换股吸收合并 中国船舶重工股份有限公司暨关联交易 之 独立财务顾问报告 独立财务顾问 二〇二五年七月 中信建投证券股份有限公司 关于中国船舶工业股份有限公司换股吸收合并中国船舶重工股份有限公司暨关联交易之独立财务顾问报告 声明和承诺 中信建投证券股份有限公司（以下简称"中信建投证券"或"本独立财务顾问"） 受中国船舶重工股份有限公司（以下简称"中国重工"）委托，担任本次中国船舶工业 股份有限公司换股吸收合并中国重工暨关联交易的中国重工独立财务顾问，并制作本独 立财务顾问报告。 本独立财务顾问报告是依据《公司法》《证券法》《重组管理办法》《26 号准则》 《财务顾问办法》等法律、法规的有关规定，按照证券行业公认的业务标准、道德规范， 本着诚实信用、勤勉尽责的态度，遵循客观、公正原则，在认真审阅相关资料和充分了 解本次交易行为的基础上，发表独立财务顾问意见，旨在就本次交易行为做出独立、客 观和公正的评价，以供全体股东及有关各方参考。 一、独立财务顾问声明 （一）本独立财务顾问与本次交易各方无任何关联关系。本独立财务顾问本着客观、 公正的原则对本次交易出具独立 ...

证券代码：601989 证券简称：中国重工 公告编号：临 2025-044 结合中国证监会出具关于本次交易的批复等实际情况，公司对《中国船舶工 业股份有限公司换股吸收合并中国船舶重工股份有限公司暨关联交易报告书（草 案）（注册稿）》（以下简称"重组报告书注册稿"）的部分内容进行了补充和 修订，形成了《中国船舶工业股份有限公司换股吸收合并中国船舶重工股份有限 公司暨关联交易报告书》。相较重组报告书注册稿，本次修订的主要情况如下： 中国船舶重工股份有限公司 关于中国船舶工业股份有限公司换股吸收合并中国船舶重 工股份有限公司暨关联交易报告书修订说明的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中国船舶工业股份有限公司（以下简称"中国船舶"）拟以向中国船舶重工 股份有限公司（以下简称"中国重工"或"公司"）全体换股股东发行A股股票 的方式换股吸收合并中国重工（以下简称"本次交易"），中国船舶为吸收合并 方，中国重工为被吸收合并方。 2025年7月18日，中国证券监督管理委员会（以下简称"中国证监会"）出 具了《关于同意中国船舶 ...

证券代码：601989 证券简称：中国重工 公告编号：临 2025-043 2025 年 7 月 18 日，中国证券监督管理委员会出具了《关于同意中国船舶工 业股份有限公司吸收合并中国船舶重工股份有限公司注册的批复》（证监许可 〔2025〕1501 号）（以下简称"中国证监会批复"）。 中国证监会批复的主要内 容如下： "一、同意中国船舶工业股份有限公司以新增 3,053,192,530 股股份吸收合 并中国船舶重工股份有限公司的注册申请。 二、你们本次吸收合并应当严格按照报送上海证券交易所的有关申请文件 进行。 三、你们应当按照有关规定及时履行信息披露义务。 四、你们应当按照有关规定办理本次吸收合并的相关手续。 五、本批复自下发之日起 12 个月内有效。 中国船舶重工股份有限公司 关于中国船舶工业股份有限公司吸收合并中国船舶重工股 份有限公司暨关联交易事项获得中国证券监督管理委员会 同意注册批复的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中国船舶工业股份有限公司（以下简称"中国船舶"）拟以向中国船舶重工 股份有限公 ...

Group 1 - Nanjing Gaoke reported a contract sales amount of 1.021 billion yuan in the real estate sector for the first half of 2025, representing a year-on-year increase of 729.83% [1] - The company achieved a contract sales area of 6.85 million square meters in the first half of 2025, a year-on-year increase of 2437.04% [1] - Changhong High-Tech plans to acquire 100% equity of Guangxi Changke through a combination of share issuance, convertible bonds, and cash payment, which is expected to constitute a major asset restructuring [2] Group 2 - Tianyu Digital announced that its director Guo Baichun has been criminally detained for embezzlement and abuse of power, but this matter is unrelated to the company [3][10] - Weifu High-Tech intends to convert its B shares for listing on the main board of the Hong Kong Stock Exchange, with no new shares being issued [4] - Taiankang's subsidiary received approval for a clinical trial of CKBA cream for rosacea, which is expected to be the first innovative small molecule drug targeting T-cell fatty acid metabolism pathways in the autoimmune field [5] Group 3 - Hongbaoli's major shareholder and actual controller plan to reduce their holdings by no more than 2% of the company's shares due to debt repayment and personal financial needs [6] - Dongwu Securities plans to raise no more than 6 billion yuan through a private placement to fund various business expansions and debt repayments [7] - Lianhuan Pharmaceutical received approval for clinical trials of RuLuGoli tablets for prostate cancer, marking a significant step in its oncology drug development [8] Group 4 - Haipuri announced that its innovative drug H1710 has completed the first subject enrollment and dosing in Phase I clinical trials, targeting advanced solid tumors [9] - Huadong Medicine's subsidiary received approval for clinical trials of HDM2012, a first-in-class biopharmaceutical targeting human mucin-17, enhancing the company's competitiveness in cancer treatment [12] - China Shipbuilding's absorption and merger of China Shipbuilding Heavy Industry has received approval from the China Securities Regulatory Commission [14]

中国船舶：公司吸收合并中国重工事项获得证监会同意注册批复 智通财经7月18日电，中国船舶(600150.SH)公告称，公司吸收合并中国重工事项已获得中国证监会同意 注册批复。批复主要内容包括同意吸收合并申请、按规定进行信息披露和办理相关手续等。批复有效期 为12个月。公司将根据批复和相关法律法规要求，在规定期限内办理相关事宜并履行信息披露义务。 ...

证监会同意中国船舶工业股份有限公司以新增30.53亿股股份吸收合并中国船舶重工股份有限公司的注 册申请。 ...

Group 1 - The China Securities Regulatory Commission has approved China Shipbuilding Industry Co., Ltd. to absorb and merge with China Shipbuilding Heavy Industry Co., Ltd. by issuing an additional 3,053,192,530 shares [1]

Core Viewpoint - The performance of central state-owned enterprises (SOEs) listed on A-shares in the first half of the year has shown significant improvement, with 79 companies reporting positive earnings, driven by national policies and internal reforms [1] Group 1: Central SOEs Performance - 32 central SOEs achieved year-on-year growth in net profit attributable to shareholders, while 22 companies turned losses into profits, and 25 companies reduced losses [1] - 19 central SOEs have a projected upper limit for net profit growth exceeding 100%, indicating strong profitability [1] - The sectors of electric power equipment, shipbuilding, and rare earths are experiencing high demand and performance, contributing positively to the overall market [1] Group 2: Electric Power Equipment Industry - The electric power equipment industry is benefiting from national policies aimed at carbon neutrality and the construction of a new power system, leading to high-quality development [2][4] - The Ministry of Industry and Information Technology aims for an average annual revenue growth rate of over 9% for the electric power equipment industry from 2023 to 2024 [4] - Major investments in grid construction and the acceleration of ultra-high voltage projects are creating significant opportunities for electrical equipment companies [5] Group 3: Shipbuilding Industry - Despite a global downturn in shipbuilding, Chinese shipyards lead with 10.04 million CGT and 370 vessels, capturing 52% of global orders [6] - Several central SOEs in shipbuilding are expected to see substantial profit increases, with some companies projecting over 200% growth in net profit [6] - The growth is attributed to effective management, increased delivery of civilian vessels, and rising prices [6] Group 4: Rare Earth Industry - The rare earth sector is thriving due to its strategic importance and increasing demand from industries like new energy and smart manufacturing [7] - China Rare Earth anticipates a net profit of 136 million to 176 million yuan, indicating a turnaround from losses [6] - The company has adapted its marketing strategies and optimized production processes to capitalize on rising prices and demand [7] Group 5: Future Outlook - The high growth in these industries is expected to be sustainable, supported by national strategies and market demand [7] - Companies are encouraged to align with national strategies, innovate technologically, optimize supply chains, and expand into international markets to enhance growth and profitability [7]